---
title: "Livento Group, Inc. | 10-Q: FY2025 Q1 Revenue: USD 312.66 K"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/241178928.md"
published_at: "2025-05-21T08:09:53.000Z"
---

# Livento Group, Inc. | 10-Q: FY2025 Q1 Revenue: USD 312.66 K

Revenue: As of FY2025 Q1, the actual value is USD 312.66 K.

### Segment Revenue

-   **Total Revenue**: For the three months ended March 31, 2025, Livento Group, Inc. reported revenues of $306,622, primarily from sales of Elisee and management services. Additionally, $1,124,840 was recorded as movie margin income for projects entering the production phase.

### Operational Metrics

-   **Gross Profit**: The gross profit for the three months ended March 31, 2025, was - $481,147, compared to - $421,013 for the same period in 2024.
-   **Net Loss**: The net loss for the three months ended March 31, 2025, was - $677,540, compared to a net income of $555,572 for the same period in 2024.

### Cash Flow

-   **Operating Cash Flow**: Net cash used in operating activities was - $9,012 for the three months ended March 31, 2025, compared to - $90,997 for the same period in 2024.
-   **Investing Cash Flow**: Net cash used in investing activities was - $228,818 for the three months ended March 31, 2025, compared to - $53,363 for the same period in 2024.
-   **Financing Cash Flow**: Net cash provided by financing activities was $258,537 for the three months ended March 31, 2025, compared to $128,780 for the same period in 2024.

### Unique Metrics

-   **Elisee Software**: Revenue from Elisee software and management services was a significant contributor to the company’s income, with stable income from clients in Europe and the USA.

### Future Outlook and Strategy

-   **Core Business Focus**: Livento Group plans to continue leveraging its Elisee software and management services as stable income sources. The company is also focused on expanding its movie projects, which are expected to generate significant revenue as they enter production phases.
-   **Non-Core Business**: The company is exploring opportunities in real estate development, with a project in Prague expected to generate substantial returns upon completion.

### Related Stocks

- [NUGN.US - Livento Group, Inc.](https://longbridge.com/en/quote/NUGN.US.md)
- [NUGND.US - LIVENTO GROUP INC](https://longbridge.com/en/quote/NUGND.US.md)
- [LIVG.US - Livento Group, Inc.](https://longbridge.com/en/quote/LIVG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Livento Group Issues Amendment Confirming 1-for-20,000 Reverse Stock Split | Livento Group Inc. has confirmed a 1-for-20,000 reverse stock split approved by stockholders on May 5, 2025. The company | [Link](https://longbridge.com/en/news/274006335.md) |
| NuGen Medical Devices Inc. Provides Update on Health Canada License | NuGen Medical Devices Inc. has temporarily halted sales of its devices in Canada due to the expiration of its Health Can | [Link](https://longbridge.com/en/news/275039972.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.